Trial Profile
Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Antiretroviral Naive Patients With HIV/HBV Co-infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Efavirenz; Emtricitabine; Zidovudine
- Indications Hepatitis B; HIV infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 04 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Nov 2009 Results were presented at EACS 2009.
- 20 Jul 2007 New trial record.